CRISPR Therapeutics vs Editas Medicine
CRISPR Therapeutics
Gene-based medicines for patients with serious diseases
350 employees · est. 2013 · Boston, United States
Editas Medicine
What If You Could Repair Broken Genes?
178 employees · est. 2013 · Cambridge, United States
CRISPR Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | CRISPR Therapeutics | Editas Medicine |
|---|---|---|
| Founded | ||
| Founded | 2013 | 2013 |
| Headquarters | ||
| Headquarters | Boston, United States | Cambridge, United States |
| Employees | ||
| Employees | 350 larger | 178 |
| Industry | ||
| Industry | Biopharma, Biotechnology | Biotechnology |
| Funding Stage | ||
| Funding Stage | IPO | IPO |
| Total Funding | ||
| Total Funding | $1.05B | $1.03B |
| Funding Rounds | ||
| Funding Rounds | 7 | 9 |
| Services | ||
| Services | Development of gene-based medicines, Gene-editing therapies, Clinical and preclinical research, Patient advocacy | CRISPR Gene Editing Research, Development of Genomic Medicines, Clinical Trials and Pipeline Development, Manufacturing of Therapeutic Solutions |
| Target Customers | ||
| Target Customers | Patients with serious diseases, Healthcare providers, Biotechnology companies, Research institutions | Patients with Serious Diseases, Healthcare Providers, Medical Research Institutions, Biopharmaceutical Industry |
| Taxonomy | ||
| Taxonomy | Gene-based MedicinesCRISPR TechnologyGene EditingHematologyOncologyRegenerative Medicine +9 | Genome EditingCRISPR/Cas9CRISPR/Cas12aClinical Stage BiotechGenomic MedicinesPrecision Medicine +9 |
| Website | ||
| Website | crisprtx.com | editasmedicine.com |
About CRISPR Therapeutics
CRISPR Therapeutics, a leader in biopharma and biotechnology, stands at the forefront of creating gene-based medicines for patients with serious diseases. Since its founding in 2013, the company has not only evolved but thrived by leveraging CRISPR technology, a Nobel Prize-winning innovation that h...
About Editas Medicine
Editas Medicine, founded in 2013 and headquartered in the United States, is a clinical-stage genome editing company at the forefront of leveraging CRISPR/Cas9 and CRISPR/Cas12a systems for medical innovation. Their ambition is encapsulated in their slogan, "What If You Could Repair Broken Genes?", w...
Also comparing in this category
We will tell you when either one moves
BounceWatch watches CRISPR Therapeutics and Editas Medicine for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.
Get notified when CRISPR Therapeutics or Editas Medicine moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Frequently Asked Questions
Compare CRISPR Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at CRISPR Therapeutics on 3 Jul 2026, and Editas Medicine on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
